Pregnancy-specific glycoproteins (PSGs) are secreted carcinoembryonic antigen (CEA)-related cell adhesion molecules-related members of the immunoglobulin superfamily and are encoded by multigene families in species with haemochorial placentation. PSGs may be the most abundant trophoblast-derived proteins in human maternal blood in late pregnancy and there is evidence that dysregulation of PSG expression is associated with gestational pathology. PSGs are produced by syncytiotrophoblast in the human placenta and by trophoblast giant cells (TGCs) and spongiotrophoblast in rodents, and are implicated in immune regulation, angiogenesis and regulation of platelet function. PSGs are encoded by 17 genes in the mouse and ten genes in the human. While functions appear to be conserved, the typical protein domain organisation differs between species. We analysed the evolution of the mouse Psg genomic locus structure and report inversion of the Psg22 gene within the locus. Psg22 is the most abundant Psg transcript detected in the first half of mouse pregnancy and we identified antisense long non-coding RNA (lncRNA) transcripts adjacent to Psg22 associated with an active local chromatin conformation. This suggests that an epigenetic regulatory mechanism may underpin high Psg22 expression relative to the other Psg gene family members in TGCs.
Introduction
Pregnancy-specific glycoproteins (PSGs) are members of a rapidly evolving multigene family (Chuong et al. 2010) and are the most abundant foetal proteins secreted into the maternal blood during pregnancy (Lin et al. 1974) . Their concentration increases with gestational progression and reportedly reaches up to 200-400 mg/ml at term, far exceeding the concentrations of other placental hormones (Lin et al. 1974 , Lee et al. 1979 . PSGs are produced by syncytiotrophoblast (SyT) in higher primates and spongiotrophblast (SpT) and trophoblast giant cells (TGCs) in rodents (Lei et al. 1992 , Rebstock et al. 1993 , Kromer et al. 1996 . Mouse Psg genes are clustered on chromosome 7 in a region syntenic to human chromosome 19q13.2 (Teglund et al. 1994 , Rettenberger et al. 1995 . Similar to many placental hormones, PSGs are encoded by multigene families and there are ten human, 17 mouse and eight rat PSG genes (Rudert et al. 1989, www.ensembl.org) . To date, PSGs have been found exclusively in species with haemochorial placentation, in which maternal blood is in direct contact with foetal trophoblast (Wu et al. 2008 , Kammerer & Zimmermann 2010 .
PSG proteins are members of the immunoglobulin (Ig) superfamily and are closely related to the predominantly membrane-anchored carcinoembryonic antigen-related cell adhesion molecules (CEACAMs; Kammerer & Zimmermann 2010) . PSG and CEACAM family members possess a variable number of Ig variable (N)-like and Ig constant (C)-like domains and are heavily glycosylated (McLellan et al. 2005a) . The Ig-like domain complements of human and rodent PSGs differ considerably. Typically, human PSGs contain one N and a variable number of C domains, whereas rodent PSGs typically have three or more N domains followed by a single C (subtype A) domain. All rat PSGs, with the exception of PSG36 (N1-N2-N3-N4-N5-A), are of the N1-N2-N3-A domain arrangement, whereas the mouse Psg family has 14 members of the N1-N2-N3-A arrangement, and three (Psg24, Psg30 and Psg31), which have an expanded structure created by duplication of N domains (McLellan et al. 2005b) .
Notwithstanding the divergence of primate and rodent PSG protein domain complements, there is abundant evidence for conservation of function of PSGs across species. Human and mouse PSGs induce Th2 cytokine production in human and mouse monocytic and other cells (Wessells et al. 2000 , Snyder et al. 2001 , Motrán et al. 2002 , Waterhouse et al. 2002 , Ellerman et al. 2003 , Ha et al. 2005 , Blois et al. 2012 , Martínez et al. 2012 , and human PSG1 activates TGFb1 in a cell-free system and reduces inflammation in a mouse colitis model (Blois et al. 2014) . Human and mouse PSGs induce tube formation by endothelial cells in matrigel, suggesting that PSGs may be pro-angiogenic in vivo (Lisboa et al. 2011 , Blois et al. 2012 . PSGs may also have an anti-thrombotic role in pregnancy because recombinant human and mouse PSGs bind platelet integrin aIIbb3 and inhibit fibrinogen binding (Shanley et al. 2013) . Immunomodulatory and pro-angiogenic functions of PSGs may be mediated by cell binding through a variety of receptors including the tetraspanin CD9 (Waterhouse et al. 2002 ) and heparan and chondroitin sulphates (Lisboa et al. 2011 , Blois et al. 2012 .
Understanding the functions of PSGs and the clinical significance of their dysregulation during pregnancy is complicated by the multigenic nature of the family and evidence of extensive genomic variation at the individual level (Chang et al. 2013) , and the lack of specific research reagents for individual family members. Nevertheless, there is suggestive evidence of alterations in PSG expression in pregnancies complicated by intrauterine growth restriction (IUGR) and preeclampsia (PE) (Pihl et al. 2009 , Zhao et al. 2012 , Blankley et al. 2013 , reviewed in Moore & Dveksler (2014 ). Several studies reported reduced global PSG expression in IUGR and PE (Pihl et al. 2009 , Zhao et al. 2012 , and a recent study, using proteomic analysis of maternal sera by mass spectrometry, has reported increased levels of PSG9 in PE (Blankley et al. 2013) .
PSGs are expressed almost exclusively in trophoblastic tissues of the foetal component of the placenta, with no evidence of fine regulation of individual family members in different cell types or in response to physiological stimuli. However, there is some evidence for temporal modulation. Psg mRNA expression in the first half of mouse pregnancy is almost exclusively due to Psg22 expression in TGCs (Wynne et al. 2006) , and human PSGs are differentially expressed between the first trimester and the term (Shanley et al. 2013) . PSGs may have both individual gene regulation and more global locus-wide regulation at the transcriptional level. Human PSG gene promoters have been analysed structurally and in reporter assays, and several transcription factors have been implicated including SP1 (Nores et al. 2004) , Krupplelike factors KLF4 and KLF6 (Blanchon et al. 2006 , Racca et al. 2011 , retinoic acid derivatives (Ló pez-Díaz et al. 2007 , Camolotto et al. 2010 and ETS family members (Chamberlin et al. 1994 , Camolotto et al. 2010 . Many PSG gene promoters contain transcription factor-binding sites conserved among multiple family members, which may explain coordinated upregulation of PSGs in cultured cells undergoing replicative senescence (Minagawa et al. 2005 , Endoh et al. 2009 ), which may mimic terminal differentiation of trophoblast cells in vivo. Virtually nothing is known about transcriptional regulation of mouse Psg genes apart from the attenuation of Ceacam and Psg expression in Inositol-requiring enzyme 1a (Ire1a) and X-box-binding protein 1 (Xbp1) knockout mice, both of which are implicated in placental development. However, it is unclear whether these factors bind directly to Psg gene regulatory regions (Oikawa et al. 2010) .
In order to achieve a deeper understanding of PSG gene evolution, expression and regulation, we completed the characterisation of mouse PSG-coding mRNA transcripts. This has identified regulated novel long noncoding RNA (lncRNA) transcripts at the mouse Psg locus, clarified evolutionary relationships between mouse and rat PSG genes and analysed the genomic context and regulation of the mouse Psg22 gene. Our findings will facilitate rational gene targeting of the Psg22 locus and may lead to increased understanding of regulation and function of this locus.
Materials and methods

Bioinformatics
All PSG sequences (genomic, coding sequences (CDS) and amino acid (aa)) were taken from public genome browsers: National Centre of Biotechnology Institute (NCBI) (http://www. ncbi.nlm.nih.gov/), University of California, Santa Cruz (UCSC) (http://genome.ucsc.edu/) and the Ensembl Genome browser (http://www.ensembl.org/index.html). Using these databases, a comprehensive list of all known rodent and human PSGs was compiled. We collated DNA sequences of all rodent PSGs and used sequence alignment tools to locate the mouse and rat PSG gene families at their respective loci. Sequence alignments were performed using online NCBI BLAST sequence alignment tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and online ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) alignment software and, additionally, using the MEGA Molecular Evolutionary Genetics Analysis software MEGA5 (http://www.megasoftware.net/), we aligned individual PSG families for mouse, rat and human PSG-CDS and constructed Phylogenetic trees (neighbour-joined pairwise comparison phylogenetic trees). The evolutionary history was inferred using the Maximum Likelihood method based on the TamuraNei model (Tamura & Nei 1993) . The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analysed (Felsenstein 1985) . The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches (Felsenstein 1985) . All major branches yielded values of 95-100%. The scale bar represents 0.1 nucleotide substitutions per site.
All primers were designed using the online Primer-Blast Software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) unless otherwise stated. Primer analysis and the potential of secondary structures in primers were assessed using the online NetPrimer Software (http://www.premierbiosoft.com/netprimer/). PCR primer sequences are listed in Supplementary Table 1, see section on supplementary data given at the end of this article.
Materials
Chemicals were purchased from Sigma-Aldrich unless otherwise stated. Restriction enzymes were purchased from New England Biolabs (Ipswich, MA, USA). T4 DNA ligases were purchased from New England Biolabs. High Fidelity Phusion2 Hot Start Thermostable DNA Polymerase was purchased from ThermoScientific (Waltham, MA, USA). Plasmid DNA isolation, gel purification and nucleotide clean-up kits were purchased from Qiagen and used according to the manufacturer's instructions. Oligonucleotide primers for PCR were purchased from Eurofins MWG Operon (Eberberg, Germany). Bacterial medium constituents were purchased from Sigma-Aldrich. Perfectly Blunt Cloning kit and Escherichia coli bacterial strains used were purchased from Novagen (EMD Bioscience, Madison, MI, USA). Plastics and mammalian tissue culture materials were purchased from Starstedt (Wexford, Ireland). DNA ladders were purchased from New England Biolabs.
Mouse tissues
Mouse tissues were obtained from the Biological Services Unit, University College Cork. Mouse strains used were CD1, C57Bl6/J, 129/Sv. Embryonic (E) stage refers to the gestational age of the embryo. The morning on which the vaginal plug was found is counted as day 1 (E1) of gestation.
Cell culture
Trophoblast stem cell (TSC) lines TS-GFP, TS-EXE and TS-R26 were maintained as described previously (Tanaka 1998 , Himeno et al. 2008 . trophoblast stem (TS) were cultured in RPMI 1640 medium supplemented with 20% foetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM 2-mercaptoethanol, 50 U/ml penicillin and 50 mg/ml streptomycin. TS were seeded in T75 flasks and kept in an undifferentiated state using TS medium plus 70% mouse embryonic fibroblast conditioned medium (FCM) with 25 ng/ml FGF4 (Sigma-Aldrich) and 1 mg/ml heparin (SigmaAldrich). TGCs were differentiated from TS lines by culturing undifferentiated in TS medium without 70FCMCFGF4/H for 6 days (Tanaka 1998 , Hemberger et al. 2004 , Senner & Hemberger 2010 ).
PCR, RT-PCR and qPCR
PCR and RT-PCR were performed using either Finnzymes Phusion Hot Start High Fidelity DNA Polymerase (ThermoScientific, F-530S) or Finnzymes Phusion 2 Hot Start High Fidelity DNA Polymerase (ThermoScientific, F-549S) on a G-Storm thermocycler (G-Storm, Somerton, Somerset, UK) in 50 ml reaction volumes. Reactions were carried out using 10 ml of 5! GC buffer, 1.2 ml dNTPs (New England Biolabs, N0447L), 1.5 ml (10 pmol) forward primer, 1.5 ml (10 pmol) reverse primer, 2 ml DMSO, 2 ml (50 mM) MgCl 2 , 1 ml template and 0.5 ml (2 U/ml) Phusion DNA Polymerase, made up to 50 ml with ddH 2 O. Cycling conditions were 98 8C for 3 min, and 35 cycles of 98 8C for 30 s, 60 8C annealing for 40 s and 72 8C for 1 or 2 min, with a final extension of 72 8C for 10 min. The sizes of the PCR/RT-PCR products were confirmed by gel electrophoresis on a standard 1.5% agarose gel stained with Safeview (NBS Biologicals, Huntingdon, Cambs, UK) and visualised by exposure to u.v. light. Primer sequences of TSC differentiation marker genes: TSC marker (Eomes) F:
and SpT marker (Tpbpa) F: 5 0 -TGAAGAGCTGAACCACTGGA-3 0 , R: 5 0 -CAGGCAGTTCATATGTTGGG-3 0 . qPCR was performed as described previously (Wynne et al. 2006) , using the ABI PRISM 7900 sequence detection system (SDS) and the SYBR GREEN qPCR Kit (Applied Biosystems). RNA was extracted from cell lines and tissues using the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. First-strand cDNA was synthesised using 1 mg total RNA in a 20 ml reaction volume using random hexamer priming and the High Capacity cDNA RT Kit (Applied Biosystems). The SYBR Green PCR Master Mix consists of Amplitaq Gold DNA polymerase, optimised PCR buffer, 25 mM MgCl 2 , dNTP mix and AmpErase UNG. All qPCRs were performed in triplicate in MicroAmp Optical 384-Well Reaction Plates (Life Technologies) in a total volume of 10 ml. The following PCR protocol was used for all qPCRs: denaturation (95 8C for 10 min), amplification and quantification repeated for 40 cycles (95 8C for 15 s, 58 8C for 30 s and 60 8C for 1 min with a single fluorescence measurement), and generation of melting curve (60-95 8C with a heating rate of 1 8C/30 s and a continuous fluorescence measurement). Thereafter, PCR products were identified by generating a melting curve, which was also used to assess the occurrence of putative PCR artefacts (primer-dimers) or non-specific PCR products. Normalisation of expression levels to the housekeeping gene, hypoxanthineguanine phosphoribosyltransferase (Hprt), was used to avoid discrepancies caused by variations in input RNA or in RT efficiencies. Results are described as mean Psg expression relative to mean Hprt expression. qPCR primer sequences are listed in Supplementary Table 1 .
Chromatin accessibility assay
Chromatin accessibility in specific genomic regions of the mouse Psg locus was measured using the EpiQ Chromatin Accessibility Assay Kit (Bio-Rad) according to the manufacturer's instructions. TSC lines (TS-R26 and TS-GFP) and their differentiated TGCs, MEFs and 3T3 cells were grown as described previously. In situ nuclease digestion was performed, cells were lysed and qPCR was performed using the Roche Lightcycler 480 system (Roche) according to the manufacturer's instructions. PCR primers used were designed according to the manufacturer's instructions and using Primer3 Software (http:// frodo.wi.mit.edu/). PCR primer sequences are listed in Supplementary Table 1. Primer efficiency was calculated using a serial dilution standard curve and efficiency was analysed using the EpiQ Chromatin Kit Data Analysis Tool software. The mouse reference (rhodopsin, Rho) and control (glyceraldehyde 3-phosphate dehydrogenase, Gapdh) gene primers used were supplied with the kit. Percentage chromatin Polysome profile and sucrose gradients TGC tissue (w20 mg) from E10 stage embryos from the CD1 mouse strain was dissected by low-power microscopy using a Nikon SMZ1500 microscope. Samples were pulverized with a mortar and pestle, precooled with liquid nitrogen, until a fine powder was obtained, adding more liquid nitrogen as necessary. Powder was lysed in 1 ml NP40 lysis buffer (20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 15 mM MgCl 2 , 20 mM dithiothreitol (DTT), 100 mg/ml cycloheximide, 0.5% Triton-X, 24 U/ml DNase, 20 U/ml Rnasin, 40 mM VRC and 1% NP40). Nuclei were then removed by microcentrifuging at 12 000 g for 10 s at 4 8C. Cytoplasmic extract was loaded onto 11 ml 10-60% sucrose gradients (10 and 60% m/v sucrose, 20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 15 mM MgCl 2 , 1 mM DTT and 100 mg/ml cycloheximide). Sucrose gradients were made as described previously (Stone 1973) . Gradients were run for 3 h at 38 000 g at 4 8C in a Beckman Coulter SW41Ti Swinging bucket rotor in an ultracentrifuge with no brake applied. After centrifugation, 40!300 ml fractions were collected carefully from the top and stored at K80 8C. Total mRNA in each fraction was determined using A260/280 u.v. spectrometer. The 40 fractions were added to their neighbouring fraction to create 20 combined fractions, which were then used for RNA extraction (Prete et al. 2007) . Fractions 20-40 were diluted with ultrapure H 2 O to reduce the concentration of sucrose. Each fraction was supplemented with 30 ml of 0.5 M EDTA (pH 5.1), 30 ml of 10% SDS (to dissociate ribosomes) and 600 ml of phenol-chloroform-isoamyl alcohol mixture at acidic pH 5. Samples were vortexed and the upper aqueous phase was placed into a new tube supplemented with 60 ml 3 M NaOAc, pH 5.1, 2 ml GlycoBlue and 1 ml isopropanol. This was stored at K80 8C overnight. Fractions were thawed and microcentrifuged at 12 000 g for 15 min at 4 8C. The pellets were then washed with 80% EtOH, and the pellet was dried and dissolved in 50 ml H 2 O. Purified RNA concentrations were determined using a u.v. spectrometer at an absorbance of A260 nm, and stored at K80 8C. RNA was used in cDNA synthesis and qPCR was used to determine which sucrose fractions contained Psg22 transcripts. PCR primer sequences are listed in Supplementary Table 1 .
Data and statistical analysis
All graphs were created using GraphPad Prism Software (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Characterisation of mouse and rat PSG loci
Accession numbers of mouse and rat PSG genes, mRNA and protein sequences were collated from RefSeq (NCBI), Ensembl and UCSC genome browsers (Supplementary  Table 2 , see section on supplementary data given at the end of this article; mouse Psg gene synonyms and GenBank accession numbers are given in Supplementary  Table 3 ). Using these data and the BLAST program, each mouse or rat Psg mRNA sequence was aligned to w2 Mb of genomic sequence from NCBI: M38:7: 17566974 to 19627308 of mouse chromosome (chr.) 7 or to w1.3 Mb of genomic sequence from NCBI: RGSC3.4:1: 77301714 to 78604399 of rat chr. 1. From these data, we compiled updated genomic maps of mouse and rat Psg loci (Fig. 1A) . These maps indicate that Psg locus structure is highly conserved between mouse and rat; the rat has eight Psg genes, two of which are flanked by the MHC I-like leukocyte 1 genes, Mill1 and Mill2. In mouse, there are 11 genes in the Mill1/Mill2-flanked cluster, indicating significant gene duplication or loss between these species since a common ancestor. The Mill1/Mill2-flanked Psg genes in the mouse are all of the domain complement structure N1-N2-N3-A and, similar to the rat, are transcribed in the opposite orientation to Psg genes outside the Mill1/Mill2 cluster. However, mouse Psg22 is exceptional and is transcribed in the opposite orientation to other Psg genes within the Mill1/Mill2-flanked cluster.
The inverted orientation of Psg22 could be a C57Bl/6 strain-specific event; however, we found that a similar orientation is present in the 129/Sv strain because one of the boundaries of the cloned Psg locus region in PAC clone no. 647-D4 bisects the Psg22 gene, and end-sequencing of this clone allowed us to establish the There are no detectable orthologous relationships between rodent and primate PSG gene families. To determine whether such relationships are evident within rodent species, phylogenetic analysis was performed using full-length CDS sequences of mouse and rat PSGs. All mouse Psgs encoded by genes in the Mill1/Mill2 cluster are located on one major branch of the neighbour-joining (N-J) tree (Fig. 1B) . Similarly, in rat, Mill1/Mill2-flanked Psg37 and Psg39 branch together (Fig. 1B) . A phylogenetic analysis using combined rat and mouse CDS sequences indicated strong orthology between six PSGs that map outside the Mill1/Mill2-flanked cluster (Fig. 1B) . All of the major N-J tree branches yielded confidence values of 95-100%. Moreover, consistent with the sequence analysis, PSG gene order outside of the Mill1/Mill2 cluster is conserved between mouse and rat (Fig. 1A) .
To complete the description of the mouse Psg gene family, we characterised Psg31 and Psg32 which were previously reported as a pseudogene (LOC381852/ Gm5155) and a hypothetical gene (Psg-ps1, Cea6), respectively, in NCBI databases (Beauchemin et al. 1999 , McLellan et al. 2005b . Using the BLAST alignment programme, Psg31 and Psg32 sequences were aligned to a genomic contig as described above and their exonic structures were mapped ( Fig. 2A) . Expression and exonic structure of these genes were determined using a series of overlapping primer sets spanning the Psg31 transcript, and a single primer set spanning the Psg32 transcript ( Fig. 2A and B) . Using RT-PCR, we amplified these sequences from E15 placental cDNA and purified amplicons were subcloned into pSTblue-1 vector and transformed into NovaBlue Singles competent cells (Novagen, EMD Bioscience, Madison, MI, USA). Positive clones were identified by a diagnostic PCR screen of bacterial colonies and were sent in triplicate for sequencing, which confirmed expression of Psg31 and Psg32. In addition, we deduced that Psg31 has ten coding exons encoding the predicted largest mouse PSG protein with eight N domains and one A domain. Psg32 structure is similar to the majority of mouse Psgs, with five exons encoding three protein N domains and one A domain (Supplementary Figure 1 , see section on supplementary data given at the end of this article).
Psg22 expression in TGCs is developmentally regulated and its mRNA is associated with polysomes
Psg22 is by far the most abundant Psg transcript in TGCs in early pregnancy, although its expression is considerably lower than total Psg expression in the SpT later in pregnancy (Wynne et al. 2006) . To analyse whether Psg22 expression in TGCs is merely 'leaky' expression and possibly functionally unimportant, we determined its expression and regulation using two TSC lines TS-EXE and TS-GFP, which were induced to differentiate into TGCs in vitro. We characterised the relative expression of different Psg genes using two degenerate primer sets that give unbiased amplification of all mouse Psg transcripts using RT-PCR, as described previously (Wynne et al. 2006) . cDNA was synthesised from total RNA extracted from undifferentiated and differentiated TS line cultures. Purified amplicons were subcloned into pSTblue-1 vector and transformed into NovaBlue Singles competent cells (Novagen, EMD Bioscience, Madison, MI, USA). Positive clones were identified by a diagnostic PCR screen of bacterial colonies. Ten PCR clones arising from each primer set from both TS lines (in both undifferentiated and differentiated states) were sequenced (80 PCR clones in total). Undifferentiated TS lines expressed multiple Psgs with Psg22 and Psg27 predominant ( Fig. 3A and B) . However, following differentiation of TS lines to TGCs as confirmed by increased expression of TGC/ SpT markers Pl2 and Tpbpa (Supplementary Figure 2 , see section on supplementary data given at the end of this article), Psg22 is predominantly expressed (80% of total; Fig. 3C and D) . We further found, using Psg gene-specific primers in a qPCR experiment, that TS differentiation was associated with strong upregulation of Psg22 expression (greater than three orders of magnitude), with less dramatic changes in expression of Psg19, which is closely related to Psg22, and Psg21 and Psg23, which are predominantly expressed in SpT (Fig. 4A, B, C and D) . A similar pattern of high expression of Psg22 relative to these three Psg genes in TGCs, and high expression of Psg22 in TGCs relative to other placental tissues was found in a qPCR experiment using dissected placental tissues (Fig. 5A , B, C and D).
We used sucrose gradient fractionation to determine whether Psg22 in TGCs is associated with ribosomes and therefore likely to be translated. TGC tissue was dissected from three E10 embryos and processed as described in 'Materials and methods' section. U.v. spectrometry results were plotted to produce a fractionated RNA profile. Free mRNPs (fractions 1-13), 80S RNA (fractions 16-20) and polysome-bound RNA (fractions 30-39), are evident (Fig. 6A ). Fractions were combined (1C2.39C40), giving 20 in total, and fractions containing Psg22 transcripts were determined using qPCR with Psg22-specific primers of cDNA made from RNA extracted from each pair of combined fractions. qPCR of the housekeeping gene, Hprt, was used as a control. Similar to Hprt, Psg22 transcripts were enriched in fractions w15-20, indicating significant association with ribosomes ( Fig. 6B and C) .
LncRNA expression and open chromatin conformation adjacent to Psg22 is associated with differentiation of TGCs
Psg22 is flanked by Psg19 and Psg20 within a cluster of 11 Psg genes. We hypothesised that inversion of Psg22 on the chromosome relative to other Psg genes might explain its unique expression pattern in TGCs. A search of genome browsers identified a 417 bp expressed sequence tag (BY564540) w5738 bp upstream of the Psg22 transcriptional start site (TSS) and transcribed from the opposite strand (Fig. 7A) . BLAST searching of the Psg locus using the BY564540 sequence identified three regions of similarity (Fig. 7A) . The highest (90%) match located w9264 bp downstream of the Psg22 TGA stop codon is hereafter named Blast1. Two other regions (Blast2 and Blast3) were 86 and 81% similar respectively (Fig. 7A) . Blast1, downstream of Psg22, is in the same orientation as BY564540, whereas Blast2 and Blast3 are in the opposite orientation. Expression analysis of BY564540 using RT-PCR showed that it is expressed in differentiated extraembryonic lineages including EPC, TGCs and whole placenta at E13, E15 and E17, but not in undifferentiated ES cells or TSCs (Fig. 7B) . Similarly, the three related regions (Blast1, Blast2 and Blast 3) are also expressed in differentiated, but not undifferentiated, TSCs (Fig. 7B) . None of these four expressed sequences contains an open reading frame or microRNAs, as determined by ORF finder software at www.ncbi.nlm.nih.gov/projects/gorf/gorf.html, SMART Domain finder software at http://smart.embl-heidelberg.de/ and scrutiny of www.mirbase.org. We mapped the structure of the BY564540 and Blast1 transcripts to determine the extent of antisense transcription in the Psg22 region using sets of overlapping PCR primers for RT-PCR of cDNA from E10 TGCs dissected from CD1 mice (Fig. 7C and Supplementary Table 1 ). Transcript lengths (assuming no splicing events) were estimated as the distance between the most 5 0 and 3 0 primers that amplified an expressed sequence and were 6148 bp (BY564540) and 6606 bp (Blast1) respectively. We attempted to use 5 0 -RACE PCR to precisely map the TSS of the transcripts, but were unsuccessful. However, we deduce from PCR walking experiments that BY564540 transcription initiates at the 5 0 UTR of Psg22, and Blast1 initiates !1500 bp from a U6 snRNA gene (Fig. 7D) .
We used a proprietary EpiQ chromatin assay to analyse chromatin accessibility in the Psg22 gene region to determine whether lncRNA expression is associated with enhanced chromatin accessibility. Chromatin preparations were made from TS lines TS-R26 and TS-GFP before and after differentiation to TGCs. Following nuclease digestion, PCR primers from regions of interest were used to assess the degree of chromatin accessibility using proprietary software. Primers used spanned the Psg22 gene TSS; the Psg23 TSS; the BY564540 EST and Blast1 sequences, and regions 2 kb upstream and downstream of them (Fig. 8A) . Percentage chromatin accessibilities (normalised to assay controls) are shown ( Fig. 8B and C) . Briefly, none of the regions exhibit open chromatin in undifferentiated TSC samples ( Fig. 8B and C) . However, following differentiation to TGCs, Psg22 core promoter region; and BY564540 EST and Blast1 sequences and associated upstream, but not downstream, sequences all exhibit open chromatin ( Fig. 8B and C) .
Discussion
Our description of the mouse and rat Psg loci indicates that orthologous relationships are discernible between individual mouse and rat Psg genes, except within the 
2 0 2 1 2 3 2 4 2 6 2 7 2 8 2 9 3 0 3 1 3 2 2 2 /2 5 1 6 1 7 1 8 1 9 2 0 2 1 2 3 2 4 2 6 2 7 2 8 2 9 3 0 3 1 3 2 2 2 /2 5 Figure 3 Relative expression of mouse Psgs in undifferentiated (TSC) and differentiated (TGC) trophoblast cell lines. (A) TS-GFP; (B) TS-EXE; (C) GC-GFP and (D) GC-EXE. RT-PCR performed using primer sets PSGF/R (hatched) and Psg-All2F/R (open) that give unbiased amplification of all mouse Psgs. Twenty cloned PCR products (ten from each primer set) were sequenced from each cell line and the results were combined. Psg22 and Psg25 results are combined because primer set PSGF/R does not discriminate between them; however, primer set PSG-All2F/R does, and all sequenced PCR clones were Psg22. 
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Expression normalised to Hprt Expression normalised to Hprt Expression normalised to Hprt Mill1/Mill2-flanked cluster, where there has been considerable expansion of the mouse Psg gene complement. The reason for this expansion is unknown; however, it has been proposed that PSGs, similar to other placental hormones, may be subject to evolutionary selection pressures arising from maternal-foetal conflict, which could underpin gene duplication to increase gene dosage or to diversify the functionality of the locus (Haig 1993 , Ball et al. 2004 , McLellan et al. 2005b , Wynne et al. 2006 , Shanley et al. 2013 . Rapid evolution of PSGs is also evident in the lack of orthologous relationships between rodent and primate PSGs, the extreme individual variability of the human locus and the rapid evolution of human PSG-CDS (McLellan et al. 2005b , Kammerer & Zimmermann 2010 , Chang et al. 2013 . Interestingly, in a recent study of biomarkers of PE, PSG9, alone among human PSGs, was significantly upregulated, suggesting that individual PSGs may encode unique functions or undergo gene-specific regulation or pathological dysregulation (Blankley et al. 2013) . PSG functional diversification could also arise from expansion of PSG protein domain number. While most rodent PSGs have a N1-N2-N3-A domain structure encoded by five exons, in this study, we found that Psg31 has ten coding exons encoding the predicted largest mouse PSG protein comprising eight N domains and one A domain. However, it should be noted that functional studies to date have not reported differences between different mouse or human PSGs in multiple assays, suggesting that at least the currently known functions of PSGs are conserved across rodent and primate gene families (McLellan et al. 2005b , Shanley et al. 2013 . Therefore, the diversification of PSG protein structure may suggest other undetected functions for PSGs, or relaxed constraint arising from redundancy within the family. Understanding these aspects of PSG evolution will require detailed functional analysis of individual PSGs using mutagenesis in model organisms, or association of human PSG variants with pregnancy phenotypes or disorders.
We have previously demonstrated that total mouse Psg gene expression is markedly increased in the SpT compared with TGCs, and that the majority of Psg transcripts expressed in the TGCs in the first half of pregnancy are encoded by Psg22 (Wynne et al. 2006) . Psg22 is reportedly proangiogenic and its expression in TGCs may promote vascular development in the placental bed or regulate the maternal vascular C E 1 1 E P C E 1 0 E P C E 1 1 P la c E 1 3 P la c E 1 5 P la c E 1 7
Figure 5 Expression of selected mouse Psgs in primary trophoblastic tissues. Dissected TGCs (DGC; E10 and E11), ectoplacental cone (EPC; E10 and E11), and whole placenta (Plac; E13, E15 and E17).
Psg expression normalised to Hprt expression. nZ2. endothelium (Blois et al. 2012) . However, little is known about Psg22 regulation or whether its expression in TGCs is functionally significant. In this study, we found that Psg22 is strongly induced upon differentiation of TSC to TGCs in vitro, compared with its closely related paralogue Psg19, or to the closely related Psg21 and Psg23 gene pair, which are relatively highly expressed in SpT compared with TGCs. We found that the Psg22 locus has an inverted orientation relative to other Psg genes, within the Mill1/Mill2 Psg cluster, which we speculate may explain its unique regulation relative to other mouse Psgs. This configuration is present in both the C57Bl/6 and 129/Sv strains, suggesting that it is not a recent laboratory mouse strain mutation. Allied to this, we found evidence of extensive non-coding RNA transcription (lncRNA) associated with conserved sequences flanking the Psg22 gene, elements that may have undergone duplication arising from the inversion event. Moreover, using an in vitro TSC differentiation model, we showed that, similar to Psg22, these lncRNAs are developmentally regulated. To further understand the significance of lncRNA expression at the Psg22 locus, we analysed chromatin structure in the Psg22 core promoter and in regions upstream and downstream of the BY564540 and Blast1 lncRNA transcriptional units. Consistent with specific developmental regulation of Psg22 and associated lncRNA expression, we found that chromatin accessibility increased following differentiation of TSCs to TGCs. Open chromatin is generally associated with permissive or active gene promoters and other regulatory elements such as enhancers, and with lncRNA expression (Cheung & Lau 2005 , Amaral & Mattick 2008 , Mattick et al. 2009 , Ma et al. 2012 , Rinn & Chang 2012 . Significantly, 2 kb regions upstream, but not downstream, of lncRNAs exhibited increased sensitivity to nuclease following TSC differentiation, suggesting that lncRNA expression is associated with specific regulatory regions, rather than being a reflection of a global Psg locus-wide increase in chromatin accessibility. Moreover, a region spanning the TSS of the Psg23 gene, which is highly expressed in SpT but not in TGCs, did not exhibit increased accessibility in these experiments indicating that the chromatin response to TSC differentiation to TGCs may be specific to Psg22 and associated lncRNAs and not a general feature of the locus (Fig. 8B) .
Our attempts to define the lncRNA TSS using 5 0 -RACE PCR were unsuccessful. Therefore, we used series of overlapping PCR primers in genome walking experiments to identify the approximate locations of lncRNA TSS. The location of the BY564540 TSS in the Psg22 5 0 UTR indicates that this transcript partly overlaps the Psg22 transcript and suggests that the open chromatin conformation associated with the expression of the BY564540 may facilitate access of transcriptional regulators to the Psg22 promoter. The fact that the BY564540 transcript is apparently non-coding, lacks a polyA tail, has concordant expression with, and is transcribed antisense to, Psg22, suggests that it may function as an enhancer RNA (eRNA; De Santa et al. 2010 , Kim et al. 2010 , Rinn & Chang 2012 . Blast analysis of BY564540 EST identified similar regions within the Psg locus. The Blast1 region downstream of Psg22 and two other regions located upstream of Psg19 (Blast2) and upstream of Psg25 (Blast3) are all expressed in TGCs but not TSCs, and may contribute to enhancermediated Psg expression. The exact mechanism of these putative eRNAs is yet to be elucidated but may involve an RNA:RNA hybrid of lncRNA with a nascent coding transcript (Bonasio et al. 2010 , Hung & Chang 2010 . Our evidence of specific regulation of Psg22 during TGC differentiation suggests that it is involved in regulating placentation or maternal physiology. Although lacking a specific anti-Psg22 antibody, we nevertheless showed that Psg22 in TGCs is associated with polysomes suggesting that it is translated. These observations all point to a role for Psg22 expression in regulating placentation or other aspects of pregnancy, rather than merely being leaky or coincidental expression from this complex locus.
We have previously demonstrated that the tetraspanin CD9, a receptor for several mouse Psgs including Psg22, is strongly expressed in the decidua and maternal vasculature in early mouse gestation (Wynne et al. 2006) . A polyclonal antiserum raised against Psg23 that is likely to cross-react with multiple Psgs (although this has not been extensively tested), stained maternal vascular endothelium in histological sections of early implantation sites, consistent with binding of Psg22 to CD9 expressed on maternal tissues (Wynne et al. 2006) . We have previously reported, using embryo transfer experiments of WT embryos into Cd9 null mice, that CD9 was not essential for successful pregnancy (Wynne et al. 2006 ). However, a recent report has indicated that maternal CD9 is critical for uterine repair following parturition, and therefore we speculate that putative binding of Psg22 to CD9 may regulate endometrial function or repair. This report, combined with our current findings, suggest Psg22 as a strong candidate for further functional studies including gene targeting to produce a null mutant.
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